Burkett Financial Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$51.8K Hold
600
– – 0.02% 150
2026
Q2
$54.3K Hold
600
– – 0.02% 92
2026
Q1
$48K Hold
600
– – 0.02% 102
2025
Q4
$51.1K Hold
600
– – 0.02% 97
2025
Q3
$46.7K Hold
600
– – 0.02% 97
2025
Q2
$46.9K Hold
600
– – 0.02% 97
2025
Q1
$43.5K Hold
600
– – 0.02% 98
2024
Q4
$44.4K Hold
600
– – 0.02% 91
2024
Q3
$39.6K Hold
600
– – 0.02% 92
2024
Q2
$55.4K Hold
600
– – 0.03% 74
2024
Q1
$57.3K Hold
600
– – 0.03% 79
2023
Q4
$45.8K Buy
+600
New +$41.7K 0.03% 85

Other funds holding EW

Burkett Financial Services's EW Position: Q3 2026 in Review

Burkett Financial Services held its Edwards Lifesciences (EW) position steady in Q3 2026 at 600 shares worth $51.8K. The position accounts for 0.02% of the portfolio, ranked #150.

Burkett Financial Services first reported a position in EW in Q4 2023 and has held it in 12 quarters since. The position peaked at $57.3K in Q1 2024. 54 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Burkett Financial Services held 600 shares of Edwards Lifesciences worth $51.8K as of Q3 2026.
  • Burkett Financial Services left its Edwards Lifesciences share count unchanged in Q3 2026.
  • Edwards Lifesciences made up 0.02% of Burkett Financial Services's portfolio in Q3 2026, its #150 holding.
  • Burkett Financial Services first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 12 quarters since.
  • Burkett Financial Services's Edwards Lifesciences position peaked at $57.3K in Q1 2024.
  • 54 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Burkett Financial Services's 13F filing for Q3 2026, filed 1 Oct 2026.